Quantitative and Qualitative Assessment of Urinary Activity of 18F-Flotufolastat-PET/CT in Patients with Prostate Cancer: a Post Hoc Analysis of the LIGHTHOUSE and SPOTLIGHT Studies
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantitative and Qualitative Assessment of Urinary Activity of 18F-Flotufolastat-PET/CT in Patients with Prostate Cancer: a Post Hoc Analysis of the LIGHTHOUSE and SPOTLIGHT Studies
Authors
Keywords
-
Journal
MOLECULAR IMAGING AND BIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-07
DOI
10.1007/s11307-023-01867-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic Performance and Safety of 18 F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
- (2023) Ashesh B. Jani et al. JOURNAL OF UROLOGY
- Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)
- (2023) Devaki Shilpa Surasi et al. EUROPEAN UROLOGY
- Utility of 18F-rhPSMA-7.3 positron emission tomography for imaging of primary prostate cancer and pre-operative efficacy in N-staging of unfavorable intermediate to very high-risk patients validated by histopathology
- (2022) Thomas Langbein et al. JOURNAL OF NUCLEAR MEDICINE
- Combination of forced diuresis with additional late imaging in 68Ga-PSMA-11 PET/CT – effects on lesion visibility and radiotracer uptake
- (2021) Ian Alberts et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT
- (2021) Steffen Bayerschmidt et al. Diagnostics
- Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer
- (2020) Andrew Barakat et al. Scientific Reports
- Safety, biodistribution and radiation dosimetry of 18F-rhPSMA-7.3 in healthy adult volunteers
- (2020) Tuula Tolvanen et al. JOURNAL OF NUCLEAR MEDICINE
- Effect of forced diuresis during 18F-DCFPyL PET/CT in patients with prostate cancer
- (2019) Maurits Wondergem et al. NUCLEAR MEDICINE COMMUNICATIONS
- 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
- (2017) Wolfgang P. Fendler et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Frusemide aids diagnostic interpretation of 68 Ga-PSMA positron emission tomography/CT in men with prostate cancer
- (2017) Niall Fennessy et al. Journal of Medical Imaging and Radiation Oncology
- Investigation of the halo-artifact in 68Ga-PSMA-11-PET/MRI
- (2017) Thorsten Heußer et al. PLoS One
- 68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging
- (2016) Thorsten Derlin et al. EUROPEAN RADIOLOGY
- 68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
- (2016) Isabel Rauscher et al. CANCER IMAGING
- Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
- (2015) Zsolt Szabo et al. MOLECULAR IMAGING AND BIOLOGY
- Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
- (2013) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started